SightfileU.S. market data from official filings
Companies › GHRS
GH RESEARCH PLC (GHRS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001855129 · EDGAR filings · Updated 2026-06-26
GH RESEARCH PLC (GHRS) has reported institutional ownership of 76.7%, with 54 institutional managers holding positions valued at $668.5M per the latest 13F reporting period.
Institutional ownership
76.7%
Institutional managers
54
Reported 13F value
$668.5M
Latest updates
- 2026-06-26 — Foreign issuer report (6-K) filed
- 2026-06-04 — Foreign issuer report (6-K) filed
- 2026-05-21 — Foreign issuer report (6-K) filed
- 2026-05-19 — EFFECT filed
- 2026-05-18 — SCHEDULE 13G/A filed
- 2026-05-15 — CORRESP filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, GH RESEARCH PLC has 54 institutional holders and institutional ownership of 76.7%.
Related companies
KURA ONCOLOGY INC COM (KURA) · CASTLE BIOSCIENCES INC (CSTL) · BRIGHT MINDS BIOSCIENCES INC (DRUG) · SPYGLASS PHARMA INC (SGP) · TALKSPACE INC (TALK) · AVANOS MEDICAL INC (AVNS)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.